Home » Topics » Regulatory » Patents

Patents
RSS

Astra patents new pyrazolopyrimidinedione immunosuppressants

Dec. 4, 1998

Heterocyclic melatonergic agents designed at ADIR

Dec. 4, 1998

New HIV protease inhibitors in development at Monsanto

Dec. 3, 1998

Agents for ulcers synthesized and evaluated at Shiseido

Dec. 3, 1998

American Home Products describes preferential COX-2 inhibitors

Dec. 3, 1998

Taisho discloses new antitumor series

Dec. 2, 1998

Inhibitors of neovascularization (angiogenesis) patented by JT

Dec. 2, 1998

Piperidine derivatives from Sanofi useful for neurokinin-dependent pathologies

Dec. 1, 1998

New antiparasitic agents in development at Bayer

Dec. 1, 1998

Lilly describes use of dihydrobenzo[b]indenothiophenes for estrogen-related pathologies

Dec. 1, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...